At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CTOR CITIUS ONCOLOGY INC
Closed 11-13 16:00:00 EST
1.22
-0.09
-6.87%
盘后1.20
-0.02-1.64%
19:29 EST
High1.36
Low1.18
Vol76.58K
Open1.35
D1 Closing1.31
Amplitude13.74%
Mkt Cap86.99M
Tradable Cap6.41M
Total Shares71.30M
T/O93.49K
T/O Rate1.46%
Tradable Shares5.25M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Citius Pharmaceuticals reports positive early stage results of cancer combo treatment
TenX Keane Acquisition focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was incorporated in 2021 and is based in New York, New York.